RT @ericdeinmd: #EULAR2022 OP0277 MSK IRAE from Checkpoint inhibitors âï¸118 pts w MSK complaints 76% w arthralgias/m
Tweet Content
#EULAR2022 OP0277 MSK IRAE from Checkpoint inhibitors
⭐️118 pts w MSK complaints
76% w arthralgias/myalgias, 30% with inflammatory rheumatic features
Most grade 1/2, 2 grade 4 (myositis)
23 (19.5%) required d/c, time of resolution ~3 mos, 20% persistence at end of study
@RheumNow https://t.co/SINqmmjsLq
Show on Archive Page
On
Display in Search Results
On
PDQ
Off